Cardiology 2013. Part II.

Notes: Staritz, P

de Moerloose, P

Schutgens, R

Dolan, G

eng

Research Support, Non-U.S. Gov’t

England

2013/05/29 06:00

Haemophilia. 2013 Nov;19(6):833-40. doi: 10.1111/hae.12189. Epub 2013 May 28.

URL: http://www.ncbi.nlm.nih.gov/pubmed/23710576

Author Address: Department of Internal Medicine, Hemophilia Care Center Heidelberg, SRH Kurpfalzkrankenhaus, Heidelberg, Germany.

 

 

Reference Type:  Journal Article

Record Number: 905Author: Stone, G. W.

Year: 2013

Title: The next 10 years in interventional cardiology. Interview by Louise Rishton

Journal: Expert Rev Cardiovasc Ther

Volume: 11

Issue: 5

Pages: 537-40

Date: May

Short Title: The next 10 years in interventional cardiology. Interview by Louise Rishton

Alternate Journal: Expert review of cardiovascular therapy

ISSN: 1744-8344 (Electronic)

1477-9072 (Linking)

DOI: 10.1586/erc.13.50

Accession Number: 23621136

Keywords: Cardiac Catheterization/*trends

Cardiology/methods/*trends

History, 21st Century

Humans

Myocardial Infarction/surgery

Percutaneous Coronary Intervention/*methods

Abstract: Gregg Stone is Professor of Medicine at Columbia University, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapies at Columbia University Medical Center, and Co-Director of Medical Education and Research at the Cardiovascular Research Foundation in New York (NY, USA). He has served as the principle investigator for more than 70 national and international multicenter randomized trials, has authored >1000 book chapters, manuscripts and abstracts published in peer-reviewed journals, and has delivered >2000 invited lectures around the world. His areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents; adjunct pharmacology; new device angioplasty including distal embolic protection, thrombectomy, vascular brachytherapy and stent grafts; intravascular imaging; saphenous vein graft therapies; chronic total occlusions; vulnerable plaque; contrast nephropathy; mitral valve therapies; clinical trial design and regulatory issues. Along with Martin Leon, Stone is the director of Transcatheter Cardiovascular Therapeutics, the world’s largest symposium devoted to interventional cardiology and vascular medicine. Stone’s medical practice is devoted to interventional cardiology procedures at Columbia University Medical Center.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205